Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms

Circulation

Volumn 105, Issue 4, 2002, Pages 477-482

  Carrell, Tom W G ^a   Burnand, Kevin G ^a   Wells, Graham M A ^b   Clements, John M ^b   Smith, Alberto ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aneurysm; Aorta; Arteriosclerosis; Metalloproteinases; Polymerase chain reaction

Indexed keywords

COLLAGENASE 3; COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; STROMELYSIN; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 10; TISSUE INHIBITOR OF METALLOPROTEINASE 11; TISSUE INHIBITOR OF METALLOPROTEINASE 12; TISSUE INHIBITOR OF METALLOPROTEINASE 13; TISSUE INHIBITOR OF METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE 15; TISSUE INHIBITOR OF METALLOPROTEINASE 16; TISSUE INHIBITOR OF METALLOPROTEINASE 17; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TISSUE INHIBITOR OF METALLOPROTEINASE 7; TISSUE INHIBITOR OF METALLOPROTEINASE 8; TISSUE INHIBITOR OF METALLOPROTEINASE 9; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA OCCLUSION; ARTICLE; ATHEROSCLEROSIS; ENZYME ANALYSIS; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MEMBRANE BINDING; PATHOGENESIS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ABDOMINAL MUSCLES; AGED; AORTIC ANEURYSM, ABDOMINAL; AORTIC DISEASES; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANS-ACTIVATION (GENETICS);

EID: 0037192324     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0402.102621     Document Type: Article

References (35)

1. Abdominal aortic aneurysm
2. Inflammation, metalloproteinases and increased proteolysis: An emerging paradigm in aortic aneurysm
3. Elastin degradation in abdominal aortic aneurysms
4. Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples
5. An immunohistochemical study of inflammatory abdominal aortic aneurysms
6. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall
7. Mechanism of cell surface activation of 72-kDa type IV gelatinase: Isolation of the activated form of the membrane metalloproteinase
8. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms
9. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms
10. Influence of screening on the incidence of rupture abdominal aortic aneurysm: 5-Year results of a randomised controlled study
11. Abdominal aortic aneurysm rupture rates: A 7-year follow-up of the entire abdominal aortic aneurysm population detected by screening
12. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms
13. Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease
14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
15. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard
16. Elastase activity: The role of elastase in aortic aneurysm formation
17. Stress-strain characteristics and collagen-elastin content of abdominal aortic aneurysms
18. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm
19. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta
20. MMP inhibition in abdominal aortic aneurysms: Rationale for a prospective randomized clinical trial
21. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
22. The unstable atheroma
23. Matrix metalloproteinases: A review
24. Metalloproteinases and their inhibitors in matrix remodelling
25. Role of matrix metalloproteinases in abdominal aortic aneurysms
26. Quantification of matrix metalloproteinases in tissue samples
27. Quantitation of RNA using the polymerase chain reaction
28. A commentary on practical application of competitive PCR
29. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix
30. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth
31. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms
32. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
33. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms
34. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury